Literature DB >> 16474843

Recruitment of ATR to sites of ionising radiation-induced DNA damage requires ATM and components of the MRN protein complex.

K E Adams1, A L Medhurst, D A Dart, N D Lakin.   

Abstract

ATM and ATR are two related kinases essential for signalling DNA damage. Although ATM is thought to be the principle kinase responsible for signalling ionising radiation (IR)-induced DNA damage, ATR also contributes to signalling this form of genotoxic stress. However, the molecular basis of differential ATM and ATR activation in response to IR remains unclear. Here, we report that ATR is recruited to sites of IR-induced DNA damage significantly later than activation of ATM. We show that ATR is recruited to IR-induced nuclear foci in G(1) and S phase of the cell cycle, supporting a role for ATR in detecting DNA damage outside of S phase. In addition, we report that recruitment of ATR to sites of IR-induced DNA damage is concomitant with appearance of large tracts of single-stranded DNA (ssDNA) and that this event is dependent on ATM and components of the Mre11/Rad50/Nbs1 (MRN) protein complex.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16474843      PMCID: PMC1852851          DOI: 10.1038/sj.onc.1209426

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  61 in total

Review 1.  MCM proteins in DNA replication.

Authors:  B K Tye
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

Review 2.  The Mre11 complex: at the crossroads of dna repair and checkpoint signalling.

Authors:  Damien D'Amours; Stephen P Jackson
Journal:  Nat Rev Mol Cell Biol       Date:  2002-05       Impact factor: 94.444

Review 3.  A unified view of the DNA-damage checkpoint.

Authors:  Justine Melo; David Toczyski
Journal:  Curr Opin Cell Biol       Date:  2002-04       Impact factor: 8.382

4.  ATR inhibition selectively sensitizes G1 checkpoint-deficient cells to lethal premature chromatin condensation.

Authors:  P Nghiem; P K Park; Y Kim ; C Vaziri; S L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

Review 5.  Cell cycle checkpoint signaling through the ATM and ATR kinases.

Authors:  R T Abraham
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

6.  ATR is not required for p53 activation but synergizes with p53 in the replication checkpoint.

Authors:  Paul Nghiem; Peter K Park; Yong-son Kim Ys; Bimal N Desai; Stuart L Schreiber
Journal:  J Biol Chem       Date:  2001-11-15       Impact factor: 5.157

7.  Xenopus ATR is a replication-dependent chromatin-binding protein required for the DNA replication checkpoint.

Authors:  M Hekmat-Nejad; Z You; M C Yee; J W Newport; K A Cimprich
Journal:  Curr Biol       Date:  2000 Dec 14-28       Impact factor: 10.834

8.  Regulation of DNA replication fork progression through damaged DNA by the Mec1/Rad53 checkpoint.

Authors:  J A Tercero; J F Diffley
Journal:  Nature       Date:  2001-08-02       Impact factor: 49.962

9.  Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress.

Authors:  R S Tibbetts; D Cortez; K M Brumbaugh; R Scully; D Livingston; S J Elledge; R T Abraham
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

10.  Recruitment of the cell cycle checkpoint kinase ATR to chromatin during S-phase.

Authors:  D Alwyn Dart; Kate E Adams; Ildem Akerman; Nicholas D Lakin
Journal:  J Biol Chem       Date:  2004-02-09       Impact factor: 5.157

View more
  82 in total

1.  Specific role of Chk1 phosphorylations in cell survival and checkpoint activation.

Authors:  Hiroyuki Niida; Yuko Katsuno; Birendranath Banerjee; M Prakash Hande; Makoto Nakanishi
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

2.  Distinct roles of the ATR kinase and the Mre11-Rad50-Nbs1 complex in the maintenance of chromosomal stability in Arabidopsis.

Authors:  Simon Amiard; Cyril Charbonnel; Elisabeth Allain; Annie Depeiges; Charles I White; Maria Eugenia Gallego
Journal:  Plant Cell       Date:  2010-09-28       Impact factor: 11.277

3.  Human CtIP promotes DNA end resection.

Authors:  Alessandro A Sartori; Claudia Lukas; Julia Coates; Martin Mistrik; Shuang Fu; Jiri Bartek; Richard Baer; Jiri Lukas; Stephen P Jackson
Journal:  Nature       Date:  2007-10-28       Impact factor: 49.962

Review 4.  DNA damage response at functional and dysfunctional telomeres.

Authors:  Maria Pia Longhese
Journal:  Genes Dev       Date:  2008-01-15       Impact factor: 11.361

5.  DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B.

Authors:  Stela S Palii; Beth O Van Emburgh; Umesh T Sankpal; Kevin D Brown; Keith D Robertson
Journal:  Mol Cell Biol       Date:  2007-11-08       Impact factor: 4.272

6.  Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss.

Authors:  Madhav Sankunny; Rahul A Parikh; Dale W Lewis; William E Gooding; William S Saunders; Susanne M Gollin
Journal:  Genes Chromosomes Cancer       Date:  2013-11-25       Impact factor: 5.006

7.  HUS1 regulates in vivo responses to genotoxic chemotherapies.

Authors:  G Balmus; P X Lim; A Oswald; K R Hume; A Cassano; J Pierre; A Hill; W Huang; A August; T Stokol; T Southard; R S Weiss
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

Review 8.  Mouse models of DNA double-strand break repair and neurological disease.

Authors:  Pierre-Olivier Frappart; Peter J McKinnon
Journal:  DNA Repair (Amst)       Date:  2008-05-23

9.  The DNA-damage response: new molecular insights and new approaches to cancer therapy.

Authors:  Stephen P Jackson
Journal:  Biochem Soc Trans       Date:  2009-06       Impact factor: 5.407

10.  Distinct roles of ATR and DNA-PKcs in triggering DNA damage responses in ATM-deficient cells.

Authors:  Nozomi Tomimatsu; Bipasha Mukherjee; Sandeep Burma
Journal:  EMBO Rep       Date:  2009-05-15       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.